These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
450 related articles for article (PubMed ID: 20823086)
1. Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease. Parchi P; Cescatti M; Notari S; Schulz-Schaeffer WJ; Capellari S; Giese A; Zou WQ; Kretzschmar H; Ghetti B; Brown P Brain; 2010 Oct; 133(10):3030-42. PubMed ID: 20823086 [TBL] [Abstract][Full Text] [Related]
3. Defining the phenotypic spectrum of sporadic Creutzfeldt-Jakob disease MV2K: the kuru plaque type. Baiardi S; Mammana A; Dellavalle S; Rossi M; Redaelli V; Colaizzo E; Di Fede G; Ladogana A; Capellari S; Parchi P Brain; 2023 Aug; 146(8):3289-3300. PubMed ID: 36883639 [TBL] [Abstract][Full Text] [Related]
4. Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease. Galeno R; Di Bari MA; Nonno R; Cardone F; Sbriccoli M; Graziano S; Ingrosso L; Fiorini M; Valanzano A; Pasini G; Poleggi A; Vinci R; Ladogana A; Puopolo M; Monaco S; Agrimi U; Zanusso G; Pocchiari M J Virol; 2017 Jun; 91(11):. PubMed ID: 28298604 [TBL] [Abstract][Full Text] [Related]
5. Sporadic Creutzfeldt-Jakob Disease MM1+2C and MM1 are Identical in Transmission Properties. Kobayashi A; Matsuura Y; Iwaki T; Iwasaki Y; Yoshida M; Takahashi H; Murayama S; Takao M; Kato S; Yamada M; Mohri S; Kitamoto T Brain Pathol; 2016 Jan; 26(1):95-101. PubMed ID: 25851836 [TBL] [Abstract][Full Text] [Related]
6. Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice. Wadsworth JD; Joiner S; Linehan JM; Desbruslais M; Fox K; Cooper S; Cronier S; Asante EA; Mead S; Brandner S; Hill AF; Collinge J Proc Natl Acad Sci U S A; 2008 Mar; 105(10):3885-90. PubMed ID: 18316717 [TBL] [Abstract][Full Text] [Related]
7. Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. Bishop MT; Will RG; Manson JC Proc Natl Acad Sci U S A; 2010 Jun; 107(26):12005-10. PubMed ID: 20547859 [TBL] [Abstract][Full Text] [Related]
8. MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Meissner B; Kallenberg K; Sanchez-Juan P; Collie D; Summers DM; Almonti S; Collins SJ; Smith P; Cras P; Jansen GH; Brandel JP; Coulthart MB; Roberts H; Van Everbroeck B; Galanaud D; Mellina V; Will RG; Zerr I Neurology; 2009 Jun; 72(23):1994-2001. PubMed ID: 19506221 [TBL] [Abstract][Full Text] [Related]
9. Deciphering the pathogenesis of sporadic Creutzfeldt-Jakob disease with codon 129 M/V and type 2 abnormal prion protein. Kobayashi A; Iwasaki Y; Otsuka H; Yamada M; Yoshida M; Matsuura Y; Mohri S; Kitamoto T Acta Neuropathol Commun; 2013 Nov; 1():74. PubMed ID: 24252157 [TBL] [Abstract][Full Text] [Related]
10. Neuropathological and biochemical criteria to identify acquired Creutzfeldt-Jakob disease among presumed sporadic cases. Kobayashi A; Parchi P; Yamada M; Mohri S; Kitamoto T Neuropathology; 2016 Jun; 36(3):305-10. PubMed ID: 26669818 [TBL] [Abstract][Full Text] [Related]
11. Review. The neuropathology of kuru and variant Creutzfeldt-Jakob disease. McLean CA Philos Trans R Soc Lond B Biol Sci; 2008 Nov; 363(1510):3685-7. PubMed ID: 18849282 [TBL] [Abstract][Full Text] [Related]
12. Distinctive properties of plaque-type dura mater graft-associated Creutzfeldt-Jakob disease in cell-protein misfolding cyclic amplification. Takeuchi A; Kobayashi A; Parchi P; Yamada M; Morita M; Uno S; Kitamoto T Lab Invest; 2016 May; 96(5):581-7. PubMed ID: 26878132 [TBL] [Abstract][Full Text] [Related]
13. Novel histotypes of sporadic Creutzfeldt-Jakob disease linked to 129MV genotype. Cracco L; Puoti G; Cornacchia A; Glisic K; Lee SK; Wang Z; Cohen ML; Appleby BS; Cali I Acta Neuropathol Commun; 2023 Aug; 11(1):141. PubMed ID: 37653534 [TBL] [Abstract][Full Text] [Related]
14. Modulation of Creutzfeldt-Jakob disease prion propagation by the A224V mutation. Watts JC; Giles K; Serban A; Patel S; Oehler A; Bhardwaj S; Guan S; Greicius MD; Miller BL; DeArmond SJ; Geschwind MD; Prusiner SB Ann Neurol; 2015 Oct; 78(4):540-53. PubMed ID: 26094969 [TBL] [Abstract][Full Text] [Related]
17. Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years. Rudge P; Jaunmuktane Z; Adlard P; Bjurstrom N; Caine D; Lowe J; Norsworthy P; Hummerich H; Druyeh R; Wadsworth JD; Brandner S; Hyare H; Mead S; Collinge J Brain; 2015 Nov; 138(Pt 11):3386-99. PubMed ID: 26268531 [TBL] [Abstract][Full Text] [Related]
18. Review. The origin of the prion agent of kuru: molecular and biological strain typing. Wadsworth JD; Joiner S; Linehan JM; Asante EA; Brandner S; Collinge J Philos Trans R Soc Lond B Biol Sci; 2008 Nov; 363(1510):3747-53. PubMed ID: 18849291 [TBL] [Abstract][Full Text] [Related]
19. Sensitive protein misfolding cyclic amplification of sporadic Creutzfeldt-Jakob disease prions is strongly seed and substrate dependent. Bélondrade M; Nicot S; Mayran C; Bruyere-Ostells L; Almela F; Di Bari MA; Levavasseur E; Watts JC; Fournier-Wirth C; Lehmann S; Haïk S; Nonno R; Bougard D Sci Rep; 2021 Feb; 11(1):4058. PubMed ID: 33603091 [TBL] [Abstract][Full Text] [Related]
20. PrP mRNA and protein expression in brain and PrP(c) in CSF in Creutzfeldt-Jakob disease MM1 and VV2. Llorens F; Ansoleaga B; Garcia-Esparcia P; Zafar S; Grau-Rivera O; López-González I; Blanco R; Carmona M; Yagüe J; Nos C; Del Río JA; Gelpí E; Zerr I; Ferrer I Prion; 2013; 7(5):383-93. PubMed ID: 24047819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]